非侵入性肝功能指標在評估肝癌預後所扮演的角色

何樹仁 ； 霍德義

《臨床醫學月刊》 82卷4期 (2018/10) Pp. 601-604

https://doi.org/10.6666/ClinMed.201810_82(4).0110

摘要

肝癌是臺灣癌症死亡的第二大原因，每年約有7,000名患者死於肝癌。肝功能或肝纖維惡化嚴重程度對於肝癌病患者的預後及治療有巨大影響。近年來非侵入性肝功能指標可應用於評估肝癌患者的肝功能或肝纖維化程度，減少因侵入性檢查造成之併發症，本文將介紹非侵入性肝功能指標在評估肝癌預後所扮演的角色。根據多中心研究(multicenter trial)結果，肝癌患者接受不同的治療，ALBI grade 最能客觀預測肝癌患者的預後。

關鍵字

肝癌(hepatocellular carcinoma, HCC) ； 非侵入性肝功能指標(noninvasive liver functional reserve models)

參考文獻

1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA: Cancer J Clin 2005;55:74-108.

2. Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology 2011;53:1020-2.

3. European Association For The Study Of The Liver, European Organisation For Research And Treatment Of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2012;56:908-43.

4. Huo TI, Lee PC, Huang YH, et al. The sequential changes of the model for end-stage liver disease score correlate with the severity of liver cirrhosis in patients with hepatocellular carcinoma undergoing locoregional therapy. J Clin Gastroenterol 2006;40:543-50.

5. Wai CT, Greenson JK, Fontana RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003;38:518-26.